Normative data for functional assessment of cancer therapy - General scale and its use for the interpretation of quality of life scores in cancer survivors

被引:95
作者
Holzner, B
Kemmler, G
Cella, D
De Paoli, C
Meraner, V
Kopp, M
Greil, R
Fleischhacker, WW
Sperner-Unterweger, B
机构
[1] Univ Innsbruck Hosp, Dept Biol Psychiat, A-6020 Innsbruck, Austria
[2] Univ Innsbruck Hosp, Dept Psychiat, A-6020 Innsbruck, Austria
[3] Univ Innsbruck Hosp, Dept Haematol & Oncol, A-6020 Innsbruck, Austria
[4] Ctr Outcomes Res & Educ, Evanston, IL USA
关键词
D O I
10.1080/02841860310023453
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aims of this study were to derive population-based reference values for the Functional Assessment of Cancer Therapy Scale - General (FACT-G) and to investigate the impact of sociodemographic variables (e.g. age, sex, health status) on these quality of life (QOL) scores, and to compare the normative QOL scores with those of various groups of cancer survivors. A random sample of 2 000 members of the Austrian public were sent questionnaires containing the FACT-G and questions relating to demographic data and health status. A total of 968 questionnaires were returned giving an overall response rate of 50.6% ( females 48.3%, age 49.3 +/- 16.8). Subjects with higher education reported higher QOL values; divorced and widowed persons had significantly lower QOL scores. Higher age was also associated with lower QOL scores. After bone marrow transplantation, patients generally showed lower QOL scores than the age- and sex-matched population-based sample, whilst in breast cancer survivors there was reduced QOL regarding social well-being. Survivors of Hodgkin's disease were found to have higher functional and social well-being scores than those of the general population sample. Sociodemographic variables should always be taken into consideration when interpreting QOL scores. Furthermore, unless patient data are compared with normative values, phenomena such as adaptation and response shift might be missed or misinterpreted.
引用
收藏
页码:153 / 160
页数:8
相关论文
共 30 条
[11]   Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries:: Results from the IQOLA Project [J].
Gandek, B ;
Ware, JE ;
Aaronson, NK ;
Alonso, J ;
Apolone, G ;
Bjorner, J ;
Brazier, J ;
Bullinger, M ;
Fukuhara, S ;
Kaasa, S ;
Leplège, A ;
Sullivan, M .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1149-1158
[12]   Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group study 9133 [J].
Ganz, PA ;
Moinpour, CM ;
Pauler, DK ;
Kornblith, AB ;
Gaynor, ER ;
Balcerzak, SP ;
Gatti, GS ;
Erba, HP ;
McCoy, S ;
Press, OW ;
Fisher, RI .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) :3512-3519
[13]  
GRAUSGRUBER A, 2001, SOZIALE SICHERHEIT, V3, P261
[14]   Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994 [J].
Greil, R ;
Holzner, B ;
Kemmler, G ;
Kopp, M ;
Buchowski, A ;
Oberaigner, W ;
Fritsch, E ;
Dirnhofer, S ;
Rueffer, U ;
Diehl, V ;
Sperner-Unterweger, B .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (05) :698-706
[15]   Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: The QLQ=C30 (+3) [J].
Hjermstad, MJ ;
Fayers, PM ;
Bjordal, K ;
Kaasa, S .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1188-1196
[16]   Quality of life in breast cancer patients -: Not enough attention for long-term survivors? [J].
Holzner, B ;
Kemmler, G ;
Kopp, M ;
Moschen, R ;
Schweigkofler, H ;
Dünser, M ;
Margreiter, R ;
Fleischhacker, WW ;
Sperner-Unterweger, B .
PSYCHOSOMATICS, 2001, 42 (02) :117-123
[17]   Comparison of two quality-of-life instruments for cancer patients:: The functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 [J].
Kemmler, G ;
Holzner, B ;
Kopp, M ;
Dünser, M ;
Margreiter, R ;
Greil, R ;
Sperner-Unterweger, B .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2932-2940
[18]   Practice and policy of measuring quality of life and health economics in cancer clinical trials: A survey among co-operative trial groups [J].
Kiebert, G ;
Wait, S ;
Bernhard, J ;
Bezjak, A ;
Cella, D ;
Day, R ;
Houghton, J ;
Moinpour, C ;
Scott, C ;
Stephens, R .
QUALITY OF LIFE RESEARCH, 2000, 9 (10) :1073-1080
[19]  
Klee M, 1997, QUAL LIFE RES, V6, P27
[20]   Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment [J].
Kopp, M ;
Schweigkofler, H ;
Holzner, B ;
Nachbaur, D ;
Niederwieser, D ;
Fleischhacker, WW ;
Sperner-Unterweger, B .
ANNALS OF HEMATOLOGY, 1998, 77 (1-2) :27-32